RaySearch publishes preliminary results for third quarter 2022 and postpones reporting date RaySearch Laboratories AB (publ) publishes preliminary figures for the third quarter of 2022. Order intake increases by 71 percent to…
Bulletin from the Extraordinary General Meeting 2022 The Extraordinary General Meeting 2022 of RaySearch Laboratories AB (publ) was held only through postal voting in accordance with temporary…
McLaren Proton Therapy Center – Karmanos Cancer Institute, selects RayStation for proton planning RaySearch Laboratories AB (publ) announces that McLaren Proton Therapy Center in Flint, Michigan, has placed an order for the treatment…
Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2022 STOCKHOLM, Oct. 21, 2022 /PRNewswire/ -- RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO…
Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2022 RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO 2022, to be held in San…
Invitation to Extraordinary General Meeting 2022 The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Extraordinary General Meeting, to…